Article
In vitro evaluation of BAY Y3118, a new full-spectrum fluoroquinolone.
Chemotherapy - 1 Jan 1992
Bremm K D, Petersen U, Metzger K G, Endermann R
Abstract excerpt
BAY Y3118, 1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8- chloro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride, is a new fluoroquinolone with antibacterial activity against an expanded spectrum of species including Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Enterococcus faecium, Streptococcus pneumoniae, Streptococcus pyogenes, and also anaerobes such as...
Topics
- Anti-Infective Agents
- Drug Resistance, Microbial
- Enterobacteriaceae
- Fluoroquinolones
- Gram-Negative Anaerobic Bacteria
- Gram-Positive Bacteria
- Microbial Sensitivity Tests
- Mutation
- Quinolones
- Time Factors